• Letter to Editor: The other side of the coin: ‘centralization’ against ‘optimization’ in COVID‐19 pandemic
• Article: Hyperinflammation as underlying mechanism predisposing patients with cardiovascular diseases for severe COVID-19
• Article: The European TeleCheck-AF project on remote app-based management of Afib during the COVID-19 pandemic: centre and patient experiences
• Article: Coronary thrombosis in a patient with COVID-19 and haemophagocytic lymphohistiocytosis   
• Article: C-reactive protein predicts outcome in COVID-19: is it also a therapeutic target?
• Article: Cardiac performance in patients hospitalized with COVID‐19: a 6 month follow‐up study
• Article: Quantitative pixel-wise analysis of native T1 mapping for identification of cardiac involvement in severe acute respiratory syndrome coronavirus 2 infection

From the European Heart Journal

• New - COVID-19 and emissions: an opportunity for sustainable global health
• New - Influenza vaccination: a ‘shot’ at INVESTing in cardiovascular health
• Exclusion of pregnant and lactating women from COVID-19 vaccine trials: a missed opportunity
• All-cause mortality and location of death in patients with CVD before, during, and after the COVID-19 lockdown
• Patterns of myocardial injury in recovered troponin-positive COVID-19 patients assessed by CMR
• Re-purposed antiviral drugs without a purpose in COVID-19: a valuable lesson for clinicians
• Xenotransplantation in the era of a zoonotic pandemic
• Characteristics and outcomes of in- and out-of-hospital cardiac arrest during COVID-19 pandemic
• C-reactive protein and clinical outcomes in patients with COVID-19
• Ventricular arrhythmia burden during the COVID-19 pandemic
• Hypertension and RAS blockers are not associated with expression of ACE2 in the kidney 
• ACE2 levels in relation to risk factors for COVID-19 in two large cohorts of patients with Afib 
• Pathological features of COVID-19-associated MI: a multicentre cardiovascular pathology study
• Management of patients needing urgent electrophysiology and/or electrostimulation procedures 
• COVID-19 is, in the end, an endothelial disease 
• Pulmonary embolism in COVID-19 patients: a French multicentre cohort study
• How COVID-19 lockdown impacts outcomes of patients with new onset atrial fibrillation
• COVID-19 kills at home: relationship between epidemic and increase of out-of-hospital cardiac arrests
• COVID-19: from epidemiology to treatment 
• Association of hypertension and antihypertensive treatment with COVID-19 mortality   
• Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era 
• Characteristics and clinical significance of cardiac injury in patients with severe COVID-19
• Circulating plasma concentrations of ACE2 in patients with HF and effects of RAA inhibitors
• Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Italy
• A tale of two countries. How to build resilient healthcare systems
• Deleterious effects of viral pneumonia on cardiovascular system
• From ‘Do No Harm’ to ‘Do Maximal Good’: an evolving concept   
  
• SARS-CoV-2: should inhibitors of the renin–angiotensin system be withdrawn in patients with COVID-19? 
• Coronaviruses and the cardiovascular system: acute and long-term implications 
  
  

From the European Heart Journal - Clinical Cases

• Major LV thrombi in an adolescent with COVID-19-associated inflammatory syndrome
• Inflammatory syndrome in children associated with COVID-19 complicated by acute MI
• Late-onset endocarditis after coronavirus disease 2019 infection
• Complete aortic thrombosis in SARS-CoV-2 infection
• Delayed diffuse inflammatory myocardial damage in a child with a history of systemic inflammatory syndrome related to COVID-19
• SCAD after COVID-19 infection presenting with ST segment elevation
• Spontaneous coronary artery dissection after COVID-19 infection presenting with ST segment elevation
• A patient with rapid worsening dyspnoea during COVID-19 pandemic
• Infectious endocarditis of the prosthetic mitral valve after COVID-19 infection
• Diagnosis of acute MI in the time of the COVID-19 pandemic
• A flare up of idiopathic hypereosinophilic syndrome due to COVID-19 
• Acute kidney injury associated with COVID-19: a prognostic factor for PE or co-incidence? 
• Collateral implications of the pandemic: belated infective endocarditis in a young patient  
• Florid aortitis following SARS-CoV-2 infection
• End-stage heart failure secondary to low-dose hydroxychloroquine treatment   
• Endomyocardial biopsy findings in Kawasaki-like disease associated with SARS-CoV-2
• Coronary artery dilatation in a child with COVID-19 and hyperinflammatory syndrome
• Large intracardiac thrombus in a COVID-19 patient treated with prolonged ECMO implantation
• Fulminant COVID-19-related myocarditis in an infant
• When a delayed consultation leads to a massive left ventricle pseudoaneurysm: collateral effects     
• Stress-induced cardiac arrest with mitral annulus disjunction in a physician amid COVID-19
• Angioedema in COVID-19 
• Percutaneous thrombectomy in a patient supported by extracorporeal membrane oxygenation 
• SARS-CoV-2, a novel virus with an unusual cardiac feature: inverted Tako-Tsubo syndrome
• Multivessel spontaneous coronary artery dissection presenting in a patient with acute SARS-CoV-2
• ST-elevation myocardial infarction and pulmonary embolism in acute respiratory distress syndrome  
• Multivessel coronary thrombosis in a patient with COVID-19 pneumonia  
• Large saddle pulmonary embolism in a woman infected with COVID-19 pneumonia  
• Typical Tako-Tsubo syndrome triggered by SARS-CoV-2 infection
• Transient complete heart block in a patient with critical COVID- 19
• COVID-19 related myocarditis in a 21-year old female patient
• Acute myocarditis as a reverse Tako-Tsubo syndrome in a patient with SARS-CoV-2 respiratory infection 
• Acute pulmonary embolism and COVID-19 pneumonia: a random association? 
• Life-threatening cardiac tamponade complicating myo-pericarditis in COVID-19 
   
  

From Cardiovascular Research 

• Double trouble: combined CV effects of particulate matter exposure and COVID-19
• Non-classical CD14^dim CD16⁺ monocytes: outcome predictors in CAD+SARS-CoV-2 patients
• Regional and global contributions of air pollution to risk of death from COVID-19
• Higher mortality of COVID-19 in males: Sex differences in immune response and CV comorbidities
• SARS-CoV-2 infects and induces cytotoxic effects in human cardiomyocytes
• The CSO cardiovascular and pulmonary imaging in COVID-19 (CISCO-19) study
• Vascular risk factors, Framingham risk score, and COVID-19: community-based cohort study
• Single-cell analysis of receptor ACE2 and spike protein priming expression of proteases in the heart
• Hospital admissions with ACS during the pandemic in German cardiac care unit
• Risk factors for myocardial injury and death in patients with COVID-19: a cohort study with chest CT 
• COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis and treatment 
• Binding of SARS-CoV-2 and angiotensin-converting enzyme 2: clinical implications  
• Hypertension, the renin–angiotensin system, and the risk of lower respiratory tract infections  
• The role of angiotensin-converting enzyme 2 in coronaviruses/influenza viruses and CVD  
• The ACE2 expression indicates new potential mechanism of heart injury in patients with SARS-CoV-2  
  
  

From European Heart Journal - Quality of Care & Clinical Outcomes

• The association between CVD admission rates, the COVID-19 lockdown and reopening of a nation: a Danish nationwide cohort study
• Admission rates and care pathways in patients with afib during the COVID-19 pandemic – Insights from Germany
• Impact of COVID-19 pandemic on acute CVD patient care and management
• Cardiovascular comorbidities as predictors for severe COVID-19 infection or death
• Impact of COVID-19 on cardiac procedure activity in England and associated 30-day mortality
• Cumulative hospitalization deficit for cardiovascular disorders in Germany during COVID-19
• Patient response, treatments and mortality for AMI during COVID-19

From European Heart Journal - Case Reports

• New - Acute submassive PE after COVID-19: reinfection or prolonged hypercoagulable state
• New - Persistent chest pain after recovery of COVID-19: microvascular disease-related angina?
• Tension posterior pneumomediastinum in acute respiratory distress syndrome due to COVID-19
• Contrast echocardiography facilitates appropriate management of hospitalized patients with COVID-19 and suspected right ventricular masses
• Impella 5.0 support before, during, and after surgical ventriculoplasty following acute MI in the COVID-19 era
• Outbreak of SARS-CoV-2: challenge for diagnosis and medical management in patients with LVAD
• Multimodality cardiac imaging for management of a cardiac mass in the era of COVID-19
• Novel findings of respiratory rate increases using the multisensor HeartLogic HF monitoring algorithm in COVID-19 patients
• Myocarditis in COVID-19 presenting with cardiogenic shock: a case series
• Ventricular septal defect complicating delayed presentation of acute MI during COVID-19 lockdown
• Gastroenteritis and cardiogenic shock in a healthcare worker
• ST-segment elevation in patients presenting with COVID-19: case series
• COVID-19 related thrombi in ascending and descending thoracic aorta with peripheral embolization
• Focal ST-segment elevation without coronary occlusion: MINOCA associated with COVID-19
• COVID-19-associated MI with no obstructive coronary arteries: the mystery of the phantom embolus or local endothelitis
• Acute PE and systemic thrombolysis during COVID-19 pandemic: example of a French cluster
• Fulminant myocarditis in a COVID-19 positive patient treated with mechanical circulatory support
• Unusual intracardiac thrombosis in two patients with COVID-19
• A case report on transient cardiomyopathy with cytokine storm in SARS-CoV-2
• Tuberculous pericarditis with tamponade diagnosed concomitantly with COVID-19
• Acute PE in COVID-19 patient: a free-floating right heart thrombus successfully treated with fibrinolysis
• Superficial temporal artery access for percutaneous coronary artery stenting during COVID-19
• Clinical spectrum of IADs associated with COVID-19: a series of four illustrative cases
• A case report of multisite arterial thrombosis in a patient with COVID-19
• Impact of COVID-19 in a child who underwent ventricular septal defect device closure
• Delayed presentation of ACS with mechanical complication during COVID-19 pandemic
• Systemic thrombolysis and anticoagulation improved biomarker measurements in massive-like PE and severe COVID-19 pneumonia
• Impact of COVID-19 in a child who underwent ventricular septal defect device closure
• Abciximab-induced alveolar haemorrhage thought to be SARS-CoV-2 in a patient with STEMI
• Recovery from respiratory failure after 49-day ECMO support in a critically ill patient with COVID-19
• Cardiac arrest and COVID-19: inflammation, ACE2, and the destabilization of non-significant CAD
• COVID-19 in situ arterial and venous thrombosis in critically ill patients: a case series
• Acute thrombosis of the right coronary artery in a patient with COVID-19
• Saddle PE and clot in transit in COVID-19 infection: a case report of catastrophic VTE
• Delayed pulmonary embolism after COVID-19 pneumonia
• COVID-19 patient with coronary thrombosis supported with ECMO and Impella 5.0 VAD
• Delayed manifestation of COVID-19 presenting as lower extremity multilevel arterial thrombosis
• Case report of SARS Co-V2 infection, acute PE, and RV thrombus
• Arterial and venous thromboembolism in a patient with severe COVID-19 pneumonia
• Fulminant micro and macroangiopathic sequalae in a patient with COVID-19
• Infective endocarditis complicating COVID-19 pneumonia
• Bi-atrial thrombosis in a patient with SARS-CoV-2 infection
• Percutaneous thrombectomy and RV MCS for a large intracardiac thrombus in a COVID-19 patient
• Myopericarditis and myositis in a patient with COVID-19: a case report
• Severe PCR-confirmed COVID-19 myocarditis in a European patient
• COVID-19 and ST elevations–keep an open mind: a case report
• COVID-19 resulting in bilateral PE and a right ventricular thrombus: association or causation?
• Coronary and cerebral thrombosis in a young patient after mild COVID-19 illness
• ECMO/CRRT combined support in critically ill patients with novel coronavirus pneumonia  
• Protecting the most vulnerable: remote management of HF patients with implantable devices  
• Pericardial effusion in patients with COVID-19: case series  
• Right atrial thrombus in a patient with COVID-19 pneumonia  
• Takotsubo cardiomyopathy in COVID-19. Haemodynamic and therapeutic considerations
• High-grade atrioventricular block in suspected COVID-19 myocarditis
• Pneumopericardium following mechanical ventilation in COVID-19 pneumonia
• The arrhythmogenic face of COVID-19: Brugada ECG pattern during acute infection
• Unusually long episodes of asystole in a severe COVID-19 patient treated with a leadless pacemaker
• Massive pulmonary embolism in a COVID-19 patient
• Drug-induced ‘Torsade de Pointes’ in a COVID-19 patient despite discontinuation of chloroquine
• Management of COVID-19 myopericarditis with reversal of cardiac dysfunction after cytokine storm
• Successful treatment of acute HF in COVID-19-induced cytokine storm with tocilizumab
• COVID-19 fulminant myocarditis 
• Intracardiac and aortic thrombi in the setting of SARS-CoV-2 infection
• STEMI in a young patient with anomalous right coronary artery and COVID-19 pneumonia
• Ventricular tachycardia storm management in a COVID-19 patient: a case report
• Case report of an isolated myocarditis due to COVID-19 infection in a paediatric patient
• COVID-19 treatment with lopinavir–ritonavir resulting in sick sinus syndrome: a case report 
• Atrial fibrillation: a risk factor for unfavourable outcome in COVID-19? A case report
• COVID19: a case report of thrombus in transit
• Cardiac sequelae of novel coronavirus disease 2019 (COVID-19): a clinical case series
• Concealed SARS-CoV-2 interstitial pneumonia unmasked by infarct-like acute myocarditis
• Case report of anterior ST-elevation myocardial infarction in a patient with coronavirus  
• Subacute perimyocarditis in a young patient with COVID-19 infection 
• Atherosclerotic spontaneous coronary artery dissection (A-SCAD) in a patient with COVID-19 
• Novel coronavirus 19 (COVID-19) associated sinus node dysfunction: a case series

From European Heart Journal - Cardiovascular Pharmacotherapy

• RAS blockers, risk of SARS-CoV-2 infection and outcomes from COVID-19: systematic review and meta-analysis
• Effect of statin therapy on SARS-CoV-2 infection-related mortality in hospitalised patients
• Management of pregnancy-related hypertensive disorders in patients infected with SARS-CoV-2
• A systematic review and meta-analysis to evaluate the clinical outcomes in COVID-19 patients on ACEis or ARBs  
• Association between renin–angiotensin system inhibitors and COVID-19 complications
• Mechanistic overview of SARS-CoV-2 using angiotensin-converting enzyme: treatment options

From European Heart Journal - Digital Health - New ESC journal

• New - AAD loading at home using remote monitoring during COVID-19
• How to adapt a hypertension prevention campaign during COVID-19: a Korean example
• Use of smartphone-operated ECG for home ECG surveillance in COVID-19 patients
• CIEDs replacement in patients followed by remote monitoring during COVID-19 lockdown

From European Heart Journal - Cardiovascular Imaging

• Early cardiac involvement in patients with acute COVID-19 infection identified by multiparametric CV MRI
• Segmental and GLS differences between children with MIS temporally associated with COVID-19 and Kawasaki disease
• Prognostic utility of quantitative offline 2D-echocardiography in hospitalised patients with COVID-19
• The evaluation of myocardial performance index in patients with COVID-19: follow-up study
• LV longitudinal strain alterations in asymptomatic or mildly symptomatic children with recent SARS-CoV-2 infection
• Clinical outcome analysis in patients with COVID-19 using echocardiography and biochemical markers
• Evolution of cardiac function in COVID-19 patients in the ICU: insights from machine learning
• Performing a cardio-thoracic MRI in COVID-19: comprehensive assessment of heart, pulmonary arteries and lungs
• Multisystem inflammatory syndrome in an adult with SARS-CoV-2 infection  
• Multimodality cardiac evaluation in children and young adults with multisystem inflammation
• Multisystem manifestations of COVID-19 in a patient presenting to a heart attack centre
• Global evaluation of echocardiography in patients with COVID-19
• CMR and serology to diagnose COVID-19 infection with primary cardiac involvement
• Myocardial work index: a glimmer of hope in COVID-19  
• Myocarditis detected after COVID-19 recovery  
• Unusual presentation of acute coronary syndrome in a patient with SARS-CoV-2 infection 
• A case of Takotsubo cardiomyopathy with COVID-19
• The role of cardiovascular imaging for myocardial injury in hospitalised COVID-19 patients 
• Myocarditis revealing COVID-19 infection in a young patient  
• Acute pulmonary embolism with intramural RV thrombus in SARS-CoV-2-positive patient 
• EACVI recommendations on precautions, indications, prioritisation, and protection

From EP Europace

• Reduction in new cardiac electronic device implantations in Catalonia during COVID-19
• Prediction of thromboembolic events and mortality by the CHADS2 and the CHA2DS2-VASc in COVID-19
• High-degree atrioventricular block in COVID-19 hospitalized patients
• Electrocardiographic findings at presentation and clinical outcome in patients with COVID-19
• Electrophysiology in the time of coronavirus: coping with the great wave
• Arrhythmic safety of hydroxychloroquine in COVID-19 patients from different clinical settings
• Electrocardiographic features of 431 consecutive, critically ill COVID-19 patients: insights
• Practice update for telehealth and arrhythmia monitoring during and after a pandemic  
• COVID-19 and QT interval prolongation: more than just drug toxicity?  

From European Journal of Heart Failure 

• December 2020 at a glance: focus on COVID‐19, comorbidities and palliative care
• Characterization of NT‐PROBNP in a large cohort of COVID‐19 patients
• Circulating cardiovascular microRNAs in critically ill COVID‐19 patients
• Association between RAASi use and COVID-19 hospitalisation and death: 1,4 million patient registry
• Hemodynamic characteristics of COVID‐19 patients with ARDS requiring MV
• HF impact on the clinical course and outcomes of COVID-19 patients: an Italian study
• In‐hospital care in AHF during the COVID‐19 pandemic: a German example
• Heart Failure in COVID-19 patients: prevalence, incidence and prognostic implication  
• Temporal trends in decompensated HF and outcomes during COVID‐19: A London multisite report
• Pathogenesis and management of myocardial injury in coronavirus disease 2019
• Viral presence guided immunomodulation in lymphocytic myocarditis: an update
• Detection of viral SARS‐CoV‐2 genomes and histopathological changes in endomyocardial biopsies
• ACE‐inhibitors and angiotensin‐2 receptor blockers not associated with severe SARS‐CoV-2 infection   
• Impact of COVID‐19 on HF hospitalisation and management: report from a HF unit in London   
• COVID-19 and heart failure: from infection to inflammation and angiotensin II stimulation 
• Consequences of COVID-19 pandemic for self‐care in-patients with a left VAD 
• Caring for people with HF beyond COVID-19: advantages of home telemonitoring
• Myocardial localisation of coronavirus in COVID‐19 cardiogenic shock

From European Heart Journal - Acute Cardiovascular Care

• Cardiovascular biomarkers in patients with COVID-19
• Cardiac complications in patients hospitalised with COVID-19
• Levels of hs-troponin I predict mortality in COVID-19 patients with cardiac injury
• Cardiac injury is associated with severe outcome and death in patients with COVID-19 infection
• Implications for prehospital, emergency and hospital care in patients with ACS  
• Respiratory management in severe acute respiratory syndrome coronavirus 2 infection  
• Cardiac safety of off-label COVID-19 drug therapy: a review and proposed monitoring protocol  
• Medical treatment options for COVID-19
• The COVID-19 epidemic, its mortality, and the role of non-pharmaceutical interventions
• Ethical aspects of the COVID-19 crisis: How to deal with an overwhelming shortage of acute beds 
• Mental health care for medical staff and affiliated healthcare workers during the COVID-19 pandemic 

From European Journal of Preventive Cardiology  

• Excess deaths in people with cardiovascular diseases during the COVID-19 pandemic
• Anticoagulation therapy in NVAF in the COVID-19 era: is it time to reconsider our therapeutic strategy?
• QTc-interval prolongation and increased risk of sudden cardiac death associated with HCQ
• Delphi consensus recommendations on how to provide CV rehab in the COVID-19 era
• Obesity, overweight and survival in critically ill patients with SARS-CoV-2 pneumonia
• Exercise in the severe SARS-CoV-2 era: Question and answer session with EAPC experts
• Effect of coronavirus infection on the human heart: A scoping review    
• Cardiac patient care during a pandemic: how to reorganise a HF unit at the time of COVID-19   
• Cardiovascular disease and COVID-19: les liaisons dangereuses
• Amiodarone as a possible therapy for coronavirus infection

From European Journal of Cardiovascular Nursing

• Facilitating transcatheter aortic valve implantation in COVID-19    
• Delivering healthcare at distance during the pandemic: experiences from clinical practice
• Delivering healthcare remotely to cardiovascular patients during COVID-19: a review of evidence

From ESC Heart Failure 

• Outcomes of COVID-19 among veterans with pre‐existing diagnosis of HF
• Impact of telemedicine on the management of HF patients during COVID-19 pandemic
• Beyond the stethoscope: managing ambulatory heart failure during the COVID‐19 pandemic
• COVID‐19 impact on the management of HF: a UK patient questionnaire study
• HFpEF in COVID-19 patients: the promising role of diuretic therapy in critically ill patients
• COVID‐19‐convalescence phase unmasks a silent MI due to coronary plaque rupture
• Myocarditis and coronary aneurysms in a child with acute respiratory syndrome coronavirus 2
• Elevated α‐HBDH as an independent prognostic factor for mortality in hospitalised COVID-19 patients
• MI in severe COVID‐19 is similar to pneumonias of other origin: results from a multicentre study
• Increased mortality and worse cardiac outcome of acute MI during the early COVID‐19 pandemic
• Recurrent autoimmune myocarditis in a young woman during the COVID-19 pandemic
• Ventricular assist device for a COVID-2019‐affected heart
• Decreased GLUT1/NHE1 RNA expression in whole blood predicts disease severity in COVID-19 patients
• Increased susceptibility to SARS‐CoV‐2 infection in patients with reduced LVEF
• Implication of inhaled nitric oxide for the treatment of critically ill COVID‐19 patients with PH
• Sudden cardiogenic shock mimicking fulminant myocarditis in a surviving COVID-19 teenager
• Delayed acute myocarditis and COVID‐19‐related multisystem inflammatory syndrome
• Reduction in heart failure hospitalisation rate during coronavirus disease 19 pandemic outbreak
• Echocardiographic abnormalities and predictors of mortality: the ECHOVID‐19 study
• Fulminant myocarditis in a patient with COVID-19 and rapid myocardial recovery after treatment
• Bedside chest ultrasound to distinguish HF from pneumonia‐related dyspnoea in older patients
• The effect of concomitant COVID‐19 infection on outcomes in patients hospitalised with HF
• Risk factors for myocardial injury in patients with coronavirus disease 2019 in China
• Impact of lockdown on patients with CHF during the pandemic
• Swollen heart in COVID‐19 patients who progress to critical illness: a perspective from echo‐cardiologists
• Fatal lymphocytic cardiac damage in COVID‐19: autopsy reveals a ferroptosis signature
• Balloon aortic valvuloplasty for urgent treatment of severe aortic stenosis during COVID-19
• Management of catheter ablation in arrhythmia patients during COVID-19
• Crosstalk between coronavirus disease 2019 and cardiovascular disease and its treatment
• The overlooked chamber in coronavirus disease 2019
• In‐hospital mortality in heart failure in Germany during the COVID‐19 pandemic
• Takotsubo syndrome as a complication in a critically ill COVID‐19 patient
• Relating ACE inhibitors or ARBs with incidence or mortality from COVID‐19
• Quarantine effect on accelerometer‐assessed physical activity of HF patients

From EuroIntervention 

• In-hospital outcomes of patients with ST-segment elevation myocardial infarction and COVID-19
• Extensive coronary artery thrombosis complicating COVID-19 infection and HLH

From other ESC sources

• Webinars - Position statements - Commentaries

• What we (don’t) know about myocardial injury after COVID-19
• Perspective - Long term effects of COVID-19 with T. Luescher and B. Parapid

• COVID-19 pandemic: complex interactions with the arrhythmic profile and the clinical course of patients with CVD
• How COVID-19 lockdown impacts outcomes of patients with new onset AFib
• Cell type-specific expression of the putative SARS-CoV-2 receptor ACE2 in human hearts
• SARS-CoV2: Use of inhibitors of the renin-angiotensin system in patients with COVID-19

Access the full podcast library on all CV topics

• A personal experience of a nurse attending to severely ill COVID-19 patients
• Getting lost in the fog of the pandemic: insights from the ‘second wave’ of COVID-19
• Brazilian nursing and the COVID-19 pandemic challenges - Brazil
• What COVID-19 is taking away from us – Milan, Italy
• WATCH - Cardiac involvement in COVID-19 - Staffordshire, UK
• COVID-19: the aftermath - Piacenza, Italy 
• Psychological support for staff – London, UK
• m-Health: Apps to the rescue – Maastricht, Netherlands  
• Connecting COVID-19 patients with their families – Madrid, Spain 
• Young cardiologist in the eye of the storm – Madrid, Spain
  
• COVID-19 patients: scared and alone - Pavia, Italy
• Protecting cardiologists during the COVID-19 epidemic – Wuhan, China 
• And the wave became a tsunami – Paris, France 
• Diagnosing the first COVID-19 patient in Italy – Codogno, Italy 
  
• Exhausted and trying to cope – Lombardy, Italy
• COVID-19: digital health swings into action

 General resources 

• Clinical, psychological, educational, and professional impact of the COVID-19 pandemic in young Spanish cardiologists
• Socioeconomic status and cardiovascular health in the COVID-19 pandemic
• WHO coronavirus disease (COVID-19) dashboard
• Presymptomatic SARS-CoV-2 infections and transmission in a skilled nursing facility 
• Epidemiology and transmission of COVID-19 in 391 cases and 1,286 of their close contacts in China 
• New NIH resource to analyse COVID-19 literature: the COVID-19 portfolio tool  
• OUP resources on COVID-19
• WHO information on COVID-19

Overview of management of coronavirus

• 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study
• Experts question guidance to reuse PPE 
• Handbook of COVID-19: Prevention and treatment

Medication

• Treatments and vaccines approved by the EMA for COVID-19
  
• Reminder of risk of serious side effects with chloroquine and hydroxychloroquine 
• ESC resources on chloroquine and cardiovascular side effects
• Thromboembolic disease: Implications for prevention, antithrombotic therapy, and follow-up

COVID-19 and CVD

• Practical recommendations for the management of diabetes in patients with COVID-19
• Renin–Angiotensin–Aldosterone system blockers and the risk of COVID-19
• Renin–Angiotensin–Aldosterone system inhibitors and risk of COVID-19
• Cardiovascular disease, drug therapy, and mortality in COVID-19
• Pulmonary and cardiac pathology in COVID-19: first autopsy series from New Orleans
• COVID-19: providing ongoing care to patients with cardiovascular disease in a pandemic
• COVID-19 and the cardiovascular system
• Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?